Literature DB >> 35112215

Insulin resistance corresponds with a progressive increase in NOD1 in high fat diet-fed mice.

Aditya Sharma1, Sushmita Singh1,2, Alok Mishra3, Amit K Rai1, Ishbal Ahmad1, Shadab Ahmad1,2, Farah Gulzar1, Jonathan D Schertzer4, Ashutosh Shrivastava3, Akhilesh K Tamrakar5,6.   

Abstract

PURPOSE: Innate immune components participate in obesity-induced inflammation, which can contribute to endocrine dysfunction during metabolic diseases. However, the chronological activation of specific immune proteins such as Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and relevance to cellular crosstalk during the progression of obesity-associated insulin resistance (IR) is not known.
METHODS: The NOD1 signaling in various insulin-sensitive metabolic tissues during the progression of diet-insulin resistance was assessed in C57BL/6J mice fed with 60% high-fat diet (HFD) for 4, 8, 12, and 16 weeks. Intestinal permeability was measured using FITC-dextran. NOD1 activating potential was analyzed using HEK-Blue mNOD1 cells.
RESULTS: HFD-fed mice showed progressive induction of glucose intolerance and impairment of insulin signaling in key metabolic tissues. We found a time-dependent increase in intestinal permeability coupled with transport and accumulation of NOD1 activating ligand in the serum of HFD-fed mice. We also observed a progressive accumulation of γ-D-glutamyl-meso-diaminopimelic acid (DAP), a microbial peptidoglycan ligand known to activate NOD1, in serum samples of the HFD-fed mice. There was also a progressive increase in transcripts levels of NOD1 in bone marrow-derived macrophages during HFD-feeding. In addition, skeletal muscle, adipose and liver, the key insulin sensitive metabolic tissues also had a time-dependent increase in transcripts of NOD1 and Rip2 and a corresponding activation of pro-inflammatory responses in these tissues.
CONCLUSION: These data highlight the correlation of inflammation and insulin resistance to NOD1 activation in the bone marrow derived macrophages and insulin responsive metabolic tissues during high fat diet feeding in mice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Glucose metabolism; Inflammation; Innate immunity; Insulin resistance; NOD

Mesh:

Substances:

Year:  2022        PMID: 35112215     DOI: 10.1007/s12020-022-02995-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  46 in total

1.  Inflammation 2010: new adventures of an old flame.

Authors:  Ruslan Medzhitov
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

3.  Curbing the Diabetes Pandemic: The Need for Global Policy Solutions.

Authors:  Frank B Hu; Ambika Satija; JoAnn E Manson
Journal:  JAMA       Date:  2015-06-16       Impact factor: 56.272

Review 4.  Macrophages, inflammation, and insulin resistance.

Authors:  Jerrold M Olefsky; Christopher K Glass
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

5.  Metabolic endotoxemia initiates obesity and insulin resistance.

Authors:  Patrice D Cani; Jacques Amar; Miguel Angel Iglesias; Marjorie Poggi; Claude Knauf; Delphine Bastelica; Audrey M Neyrinck; Francesca Fava; Kieran M Tuohy; Chantal Chabo; Aurélie Waget; Evelyne Delmée; Béatrice Cousin; Thierry Sulpice; Bernard Chamontin; Jean Ferrières; Jean-François Tanti; Glenn R Gibson; Louis Casteilla; Nathalie M Delzenne; Marie Christine Alessi; Rémy Burcelin
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

Review 6.  Insulin sensitivity: modulation by nutrients and inflammation.

Authors:  Simon Schenk; Maziyar Saberi; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Energy intake is associated with endotoxemia in apparently healthy men.

Authors:  Jacques Amar; Rémy Burcelin; Jean Bernard Ruidavets; Patrice D Cani; Josette Fauvel; Marie Christine Alessi; Bernard Chamontin; Jean Ferriéres
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

8.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

9.  An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice.

Authors:  Na Fei; Liping Zhao
Journal:  ISME J       Date:  2012-12-13       Impact factor: 10.302

10.  Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.

Authors:  Yan Y Lam; Connie W Y Ha; Craig R Campbell; Andrew J Mitchell; Anuwat Dinudom; Jan Oscarsson; David I Cook; Nicholas H Hunt; Ian D Caterson; Andrew J Holmes; Len H Storlien
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

View more
  1 in total

Review 1.  Activation of NOD1 and NOD2 in the development of liver injury and cancer.

Authors:  Naoya Omaru; Tomohiro Watanabe; Ken Kamata; Kosuke Minaga; Masatoshi Kudo
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.